108 related articles for article (PubMed ID: 25393491)
1. Protein dynamics: tuning disorder propensity in p53.
Kriwacki RW
Nat Chem Biol; 2014 Dec; 10(12):987-8. PubMed ID: 25393491
[No Abstract] [Full Text] [Related]
2. Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells.
Borcherds W; Theillet FX; Katzer A; Finzel A; Mishall KM; Powell AT; Wu H; Manieri W; Dieterich C; Selenko P; Loewer A; Daughdrill GW
Nat Chem Biol; 2014 Dec; 10(12):1000-2. PubMed ID: 25362358
[TBL] [Abstract][Full Text] [Related]
3. Fuzzy protein theory for disordered proteins.
Fuxreiter M
Biochem Soc Trans; 2020 Dec; 48(6):2557-2564. PubMed ID: 33170209
[TBL] [Abstract][Full Text] [Related]
4. Binding Kinetics of the Intrinsically Disordered p53 Family Transactivation Domains and MDM2.
Åberg E; Karlsson OA; Andersson E; Jemth P
J Phys Chem B; 2018 Jul; 122(27):6899-6905. PubMed ID: 29878773
[TBL] [Abstract][Full Text] [Related]
5. Kinetic Selection and Relaxation of the Intrinsically Disordered Region of a Protein upon Binding.
Tran DP; Kitao A
J Chem Theory Comput; 2020 Apr; 16(4):2835-2845. PubMed ID: 32192337
[TBL] [Abstract][Full Text] [Related]
6. Anchoring intrinsically disordered proteins to multiple targets: lessons from N-terminus of the p53 protein.
Huang Y; Liu Z
Int J Mol Sci; 2011 Feb; 12(2):1410-30. PubMed ID: 21541066
[TBL] [Abstract][Full Text] [Related]
7. Identifying long-range structure in the intrinsically unstructured transactivation domain of p53.
Vise P; Baral B; Stancik A; Lowry DF; Daughdrill GW
Proteins; 2007 May; 67(3):526-30. PubMed ID: 17335006
[TBL] [Abstract][Full Text] [Related]
8. Efficient Atomistic Simulation of Pathways and Calculation of Rate Constants for a Protein-Peptide Binding Process: Application to the MDM2 Protein and an Intrinsically Disordered p53 Peptide.
Zwier MC; Pratt AJ; Adelman JL; Kaus JW; Zuckerman DM; Chong LT
J Phys Chem Lett; 2016 Sep; 7(17):3440-5. PubMed ID: 27532687
[TBL] [Abstract][Full Text] [Related]
9. Targeting protein-protein interactions: lessons from p53/MDM2.
Murray JK; Gellman SH
Biopolymers; 2007; 88(5):657-86. PubMed ID: 17427181
[TBL] [Abstract][Full Text] [Related]
10. Aromatic-aromatic interactions in the formation of the MDM2-p53 complex.
Espinoza-Fonseca LM; García-Machorro J
Biochem Biophys Res Commun; 2008 Jun; 370(4):547-51. PubMed ID: 18355443
[TBL] [Abstract][Full Text] [Related]
11. Crystallographic analysis of an 8-mer p53 peptide analogue complexed with MDM2.
Sakurai K; Schubert C; Kahne D
J Am Chem Soc; 2006 Aug; 128(34):11000-1. PubMed ID: 16925398
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen Bond Dynamic Propensity Studies for Protein Binding and Drug Design.
Menéndez CA; Accordino SR; Gerbino DC; Appignanesi GA
PLoS One; 2016; 11(10):e0165767. PubMed ID: 27792778
[TBL] [Abstract][Full Text] [Related]
13. Study on the spatial architecture of p53, MDM2, and p14ARF containing complexes.
Savchenko A; Yurchenko M; Snopok B; Kashuba E
Mol Biotechnol; 2009 Mar; 41(3):270-7. PubMed ID: 18989794
[TBL] [Abstract][Full Text] [Related]
14. Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2.
Dastidar SG; Lane DP; Verma CS
J Am Chem Soc; 2008 Oct; 130(41):13514-5. PubMed ID: 18800837
[TBL] [Abstract][Full Text] [Related]
15. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft.
Showalter SA; Bruschweiler-Li L; Johnson E; Zhang F; Brüschweiler R
J Am Chem Soc; 2008 May; 130(20):6472-8. PubMed ID: 18435534
[TBL] [Abstract][Full Text] [Related]
16. Hitting a moving target: targeting transient protein states.
Bauer MR; Boeckler FM
Structure; 2013 Dec; 21(12):2095-7. PubMed ID: 24315455
[TBL] [Abstract][Full Text] [Related]
17. Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study.
Patil SP; Pacitti MF; Gilroy KS; Ruggiero JC; Griffin JD; Butera JJ; Notarfrancesco JM; Tran S; Stoddart JW
J Comput Aided Mol Des; 2015 Feb; 29(2):155-63. PubMed ID: 25377899
[TBL] [Abstract][Full Text] [Related]
18. Nondenaturing polyacrylamide gel electrophoresis to study the dissociation of the p53·MDM2/X complex by potentially anticancer compounds.
Sgammato R; Desiderio D; Lamberti A; Raimo G; Novellino E; Carotenuto A; Masullo M
Electrophoresis; 2015 Dec; 36(24):3101-4. PubMed ID: 26383830
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Potent and Selective p53-MDM2 Protein-Protein Interaction Inhibitors as Anticancer Drugs.
Holzer P
Chimia (Aarau); 2017 Oct; 71(10):716-721. PubMed ID: 29070416
[TBL] [Abstract][Full Text] [Related]
20. Structure of the stapled p53 peptide bound to Mdm2.
Baek S; Kutchukian PS; Verdine GL; Huber R; Holak TA; Lee KW; Popowicz GM
J Am Chem Soc; 2012 Jan; 134(1):103-6. PubMed ID: 22148351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
